Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

CRP-guided Antibiotic Treatment in acute exacerbations of COPD admitted to Hospital

H. J. Prins, R. Duijkers, P. van der Valk, M. Schoorl, J. M. A. Daniels, T. S. van der Werf, W. G. Boersma
European Respiratory Journal 2019; DOI: 10.1183/13993003.02014-2018
H. J. Prins
1Department Pulmonary Diseases, Northwest Hospital, Alkmaar, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Duijkers
1Department Pulmonary Diseases, Northwest Hospital, Alkmaar, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. van der Valk
2Department of Pulmonary Diseases, Medic Spectrum Twente, Enschede, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Schoorl
3Department of Clinical Chemistry, Haematology & Immunology, Northwest Hospital, Alkmaar, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. M. A. Daniels
4Department of Pulmonary Diseases, VU University Medical Center Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. S. van der Werf
5University of Groningen, Department of Pulmonary diseases and Tuberculosis, University medical Center, Groningen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. G. Boersma
1Department Pulmonary Diseases, Northwest Hospital, Alkmaar, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: w.boersma@nwz.nl
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Introduction the role of antibiotics in acute exacerbations of COPD (AECOPD) is controversial, a biomarker identifying patients who benefit from antibiotics is mandatory. We performed a RCT in patients with AECOPD comparing CRP-guided antibiotic treatment to patient reported symptoms according to GOLD strategy in order to show a reduction of antibiotic prescription

Methods patients hospitalised with AECOPD were randomised to receive antibiotics based according the GOLD strategy or according to the CRP (≥50 mg·L−1) strategy.

Results 101 patients were randomised to the CRP-group and 119 to GOLD-group. Fewer patients in the CRP-group were treated with antibiotics 31.7% versus 46.2% in the GOLD-group (p=0.028) (adjusted OR, 0.178 95%CI 0.077–0.411, p=0.029). Thirty-day treatment failure rate was equal (CRP-group 44.5% versus GOLD-group 45.5%; (p=0.881) (adjusted OR 1.146 95%CI 0.649–1.187 p=0.630) as was time to next exacerbation (CRP-group 32 days, versus GOLD-group 28 days (p=0.713) (adjusted HR0.878 (95%CI 0.649–1.187 p=0.398). Length of stay was similar in both groups (CRP-group 7 days versus GOLD-group 6 days (p=0.206). On day 30 no difference in symptoms score, quality of life or serious adverse events was detected.

Conclusion CRP as a biomarker to guide antibiotic treatment in severe AECOPD leads to a significant reduction of antibiotic treatment. In the present study no differences between both groups in adverse events were found. Further research is needed for the generalisability of these findings

Trial registration clinicaltrials.gov (NCT01232140).

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Dr. Prins has nothing to disclose.

Conflict of interest: Dr. Duijkers has nothing to disclose.

Conflict of interest: Dr. van der Valk has nothing to disclose.

Conflict of interest: Dr. Schoorl has nothing to disclose.

Conflict of interest: Dr. Daniels has nothing to disclose.

Conflict of interest: Dr. van der Werf has nothing to disclose.

Conflict of interest: Dr. Boersma reports grants from GSK, grants from Foreest Medical School, during the conduct of the study.

This is a PDF-only article. Please click on the PDF link above to read it.

  • Copyright ©ERS 2019
PreviousNext
Back to top
View this article with LENS
Vol 61 Issue 5 Table of Contents
European Respiratory Journal: 61 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
CRP-guided Antibiotic Treatment in acute exacerbations of COPD admitted to Hospital
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
CRP-guided Antibiotic Treatment in acute exacerbations of COPD admitted to Hospital
H. J. Prins, R. Duijkers, P. van der Valk, M. Schoorl, J. M. A. Daniels, T. S. van der Werf, W. G. Boersma
European Respiratory Journal Jan 2019, 1802014; DOI: 10.1183/13993003.02014-2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
CRP-guided Antibiotic Treatment in acute exacerbations of COPD admitted to Hospital
H. J. Prins, R. Duijkers, P. van der Valk, M. Schoorl, J. M. A. Daniels, T. S. van der Werf, W. G. Boersma
European Respiratory Journal Jan 2019, 1802014; DOI: 10.1183/13993003.02014-2018
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Spirometer controlled cine-MRI and TBM in paediatric patients
  • Prior CV disease and mortality COPD pneumonia patients
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society